Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-05 Sale | 2024-01-08 6:23 pm | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 23,904 | $10.79 | $257,845 | 619,096 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 6:14 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 5,994 | $10.79 | $64,656 | 107,503 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 6:01 pm | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 9,799 | $10.79 | $105,699 | 191,701 (Direct) | View |
| 2023-12-11 Sale | 2023-12-11 8:00 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 886 | $9.1301 | $8,089 | 1,997 (Direct) | View |
| 2023-06-16 Purchase | 2023-06-21 4:04 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 3,350,000 | $8.12 | $27,202,000 | 13,437,473 (Indirect) | View |
| 2023-03-28 Purchase | 2023-03-30 5:47 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 200,000 | $8 | $1,600,000 | 10,087,473 (Indirect) | View |
| 2023-03-10 Sale | 2023-03-14 5:00 pm | Zymeworks Inc. | ZYME | Klompas Neil A President & COO | 2,977 | $7.8259 | $23,298 | 20,441 (Indirect Direct) | View |
| 2023-01-19 Purchase | 2023-01-23 6:00 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 307,500 | $9.6999 | $2,982,733 | 9,887,473 (Indirect) | View |
| 2023-01-13 Purchase | 2023-01-18 6:27 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 985,100 | $9.8442 | $9,697,527 | 9,579,973 (Indirect) | View |
| 2023-01-10 Purchase | 2023-01-12 4:47 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 1,026,300 | $7.6723 | $7,874,083 | 8,594,873 (Indirect) | View |
| 2022-12-12 Sale(A) | 2022-12-23 8:00 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 887 | $6.01 | $5,331 | 2,883 (Direct) | View |
| 2022-11-10 Sale(A) | 2022-12-23 8:00 pm | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 2,475 | $8.099 | $20,045 | 26,221 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-01 Option Award | 2024-09-03 5:50 pm | N/A 2034-08-31 | Zymeworks Inc. | ZYME | PATTERSON LEONE D EVP, Chief Bus & Fin Officer | 360,000 | $0 | 360,000 (Direct) | View |
Ownership | 2024-09-03 5:45 pm | N/A N/A | Zymeworks Inc. | ZYME | PATTERSON LEONE D EVP, Chief Bus & Fin Officer | 0 | $0 | 0 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-02 9:54 pm | N/A 2034-04-01 | Zymeworks Inc. | ZYME | Gallagher Neil Director | 74,000 | $0 | 74,000 (Direct) | View |
Ownership | 2024-04-02 9:52 pm | N/A N/A | Zymeworks Inc. | ZYME | Gallagher Neil Director | 0 | $0 | 0 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 6:15 pm | N/A 2034-02-07 | Zymeworks Inc. | ZYME | Cesano Alessandra Director | 74,000 | $0 | 74,000 (Direct) | View |
Ownership | 2024-02-09 6:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Cesano Alessandra Director | 0 | $0 | 0 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:23 pm | N/A N/A | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 47,666 | $0 | 619,096 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-08 6:23 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 500,000 | $0 | 619,096 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:14 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 10,500 | $0 | 107,503 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-08 6:14 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 80,000 | $0 | 107,503 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:01 pm | N/A N/A | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 17,166 | $0 | 191,701 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-08 6:01 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 150,000 | $0 | 191,701 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-08 6:00 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2024-01-05 6:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer | 0 | $0 | 188,000 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-11 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 1,550 | $0 | 1,997 (Direct) | View |
| 2023-12-07 Option Award | 2023-12-08 5:48 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Campoy Carlos Director | 37,000 | $0 | 37,000 (Direct) | View |
| 2023-12-07 Option Award | 2023-12-08 5:41 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | RENTON HOLLINGS Director | 37,000 | $0 | 37,000 (Direct) | View |
| 2023-12-07 Option Award | 2023-12-08 5:26 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Neu Kelvin Director | 37,000 | $0 | 37,000 (Direct) | View |
| 2023-12-07 Option Award | 2023-12-08 5:26 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Cox Troy Director | 37,000 | $0 | 37,000 (Direct) | View |
| 2023-12-07 Option Award | 2023-12-08 5:22 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Mahony Susan Director | 37,000 | $0 | 37,000 (Direct) | View |
| 2023-12-07 Option Award | 2023-12-08 5:20 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Miller Derek John Michael Director | 37,000 | $0 | 37,000 (Direct) | View |
| 2023-12-07 Option Award | 2023-12-08 5:18 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Davidson Nancy Director | 74,000 | $0 | 74,000 (Direct) | View |
| 2023-12-07 Option Award | 2023-12-08 5:17 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Hillan Kenneth J. Director | 37,000 | $0 | 37,000 (Direct) | View |
Ownership | 2023-12-08 5:03 pm | N/A N/A | Zymeworks Inc. | ZYME | Davidson Nancy Director | 0 | $0 | 0 (Direct) | View |
| 2023-06-30 Option Award | 2023-06-30 8:05 pm | N/A 2033-06-29 | Zymeworks Inc. | ZYME | Campoy Carlos Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2023-06-30 8:03 pm | N/A N/A | Zymeworks Inc. | ZYME | Campoy Carlos Director | 0 | $0 | 0 (Direct) | View |
| 2023-04-10 Option Award | 2023-04-10 8:10 pm | N/A 2033-04-09 | Zymeworks Inc. | ZYME | Miller Derek John Michael Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2023-04-10 8:05 pm | N/A N/A | Zymeworks Inc. | ZYME | Miller Derek John Michael Director | 0 | $0 | 0 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 5:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A President & COO | 5,208 | $0 | 20,441 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 8:00 pm | N/A 2033-01-04 | Zymeworks Inc. | ZYME | Klompas Neil A President & COO | 146,000 | $0 | 146,000 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 8:00 pm | N/A 2033-01-04 | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 8:00 pm | N/A 2033-01-04 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 358,000 | $0 | 358,000 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 8:00 pm | N/A 2033-01-04 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 129,000 | $0 | 129,000 (Direct) | View |
| 2022-12-12 Exercise(A) | 2022-12-23 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 1,550 | $0 | 2,883 (Direct) | View |
| 2022-11-10 Exercise(A) | 2022-12-23 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 5,885 | $0 | 26,221 (Direct) | View |
| 2022-12-22 Option Award | 2022-12-23 7:30 pm | 2025-12-22 2025-12-22 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 100,000 | $0 | 100,000 (Direct) | View |